Primary sclerosing cholangitis: Present views of its pathogenesis, diagnosis and treatment

Terapevticheskii Arkhiv

Volumn 84, Issue 8, 2012, Pages 86-90

  Aleksandrova, E A ^a   Avdeyev, V G ^b   Burnevich, E Z ^a   Arion, E A ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Cholestasis; Endoscopic retrograde cholangiopancreatography; Magnetic resonance cholangiography; Primary sclerosing cholangitis; Ursodeoxycholic acid

Indexed keywords

ARTICLE; HUMAN; PRIMARY SCLEROSING CHOLANGITIS; SCLEROSING CHOLANGITIS;

CHOLANGITIS, SCLEROSING; HUMANS;

EID: 84867959712     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Schwartz S.I., Dale WA. Primary sclerosing cholangitis; review and report of six cases. Arch Surg 1958; 77:3:439-451.
2. Bambha K, Kim W.R., Tatwalkar J., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-1369. (Pubitemid 37409756)
3. Takikawa H., Takamori Y., Tanaka A., et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients. J Hepatol 1994; 21:5:787-791.
4. Hurlburt K.J., McMahon B.J., Deubner H., et al. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002; 97: 2402-2407.
5. Karlsen T.H., SchrumpfE., Boberg KM. Genetic epidemiology of primary sclerosing cholangitis. Wld J Gastroenterol 2007; 13: 41: 5421-5431. (Pubitemid 47610985)
6. Ye B. D., Yang S.-K., Boo S.-J., et al. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea. Inflammatory Bowel Diseases; n/a. doi: 10.1002/ibd.21569.
7. Olsson R., Danielsson A., Jarnerot G., et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100:1319-1323.
8. Bergquist A., Lindberg G., Saarinen S., et al. Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 2005; 42: 252-256. (Pubitemid 40143473)
9. Karlsen T.H., Franke A., Melum E., et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010; 138:3:1102-1111.
10. Karlsen T.H., Schrumpf E., Boberg KM. Update on primary sclerosing cholangitis. Dig Liver Dis 2010; 42: 390-400.
11. Borchers A. T., Shimoda S., Bowlus C., et al. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol 2009; 31:3: 309-322.
12. Cadahia V, Rodrigo L., Fuentes D., et al. Celiac disease (CD), ulcerative colitis (UC), and primary sclerosing cholangitis (PSC) in one patient: a family study. Rev Esp Enferm Dig 2005; 97: 12: 907-913. (Pubitemid 44483736)
13. Friedman K, Velez I., Pedroletti F. Benign mucous membrane pemphigoid concurrent with primary sclerosing cholangitis. FDA Todays 2009; 21:3:19-21, 23.
14. Lidar M., Langevitz P., Livneh A., et al. Sclerosing cholangitis associated with systemic sarcoidosis. J Clin Gastroenterol 2003; 36:1:84-85. (Pubitemid 36005362)
15. Chapman R., Cullen S. Etiopathogenesis of primary sclerosing cholangitis. Wld J Gastroenterol 2008; 14: 21: 3350-3359.
16. Hov J.R., Boberg KM., Karlsen T.H. Autoantibodies in primary sclerosing cholangitis. Wld J Gastroenterol 2008; 14: 24: 3781-3791.
17. Karlsen T.H., Lie BA., Frey Fmslie K., et al. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. Gastroenterology 2006; 131:3: 781-787. (Pubitemid 44307062)
18. Blanco P.G., Zaman MM., Junaidi O., et al. Induction of colitis in cftr-/- mice results in bile duct injury. Am J Physiol Gastrointest Liver Physiol 2004; 287: G491-G496. (Pubitemid 38955270)
19. Gotthardt D., Runz H., Keitel V., et al. A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults. Hepatology 2008; 48:1157-1166.
20. Bjornsson E., Boberg KM., Cullen S., et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002; 51: 731-735. (Pubitemid 35216864)
21. Angulo P., Peter J.B., Gershwin M.E., et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 2000; 32; 182-187. (Pubitemid 30093895)
22. Textor H.J., Flacke S., Pauleit D., et al. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy 2002; 34:984-990. (Pubitemid 35446329)
23. Burak K. W., Angulo P., Lindor K.D. Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol 2003; 98: 1155-1158. (Pubitemid 36733781)
24. Goss J.A., Shackleton C.R., Farmer D.G., et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997; 225:5:472-481; discus 481-483.
25. Zein C. O., Lindor K.D. Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Curr Gastroenterol Rep 2010; 12:13-22.
26. Duclos-Vallee J.C., SebaghM. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. Liver Transpl 2009; 15: Suppl2: S25-S34.